Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Current assets    
Cash and cash equivalents $ 968 $ 1,554
Marketable debt securities, available for sale 3,760 6,687
Escrow receivable 4,828 4,830
Accounts receivable, net 1,483 2,968
Inventory, net 1,886 1,903
Prepaid expenses and other current assets 294 296
Total current assets 13,219 18,238
Property, plant and equipment, net of accumulated depreciation of $6,156 and $5,854, respectively 2,382 2,499
TOTAL ASSETS 15,601 20,737
Current liabilities    
Accounts payable 374 437
Accrued advertising and other allowances 334 101
Dividend payable 2,929
Other current liabilities 365 766
Total current liabilities 1,073 4,233
Non-current liabilities:    
Deferred revenue, net of current portion 129
Total non-current liabilities 129
Total liabilities 1,202 4,233
COMMITMENTS AND CONTINGENCIES
Stockholders' equity    
Preferred stock authorized 1,000,000, $.0005 par value, no shares issued
Common stock authorized 50,000,000, $.0005 par value, issued 28,217,005 and 28,201,541 shares, respectively 14 14
Additional paid-in capital 60,027 59,471
Retained earnings 1,854 4,533
Treasury stock, at cost, 16,652,022 and 16,652,022 shares (47,490) (47,490)
Accumulated comprehensive loss (6) (24)
Total stockholders' equity 14,399 16,504
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 15,601 $ 20,737